NovellusDx Tissue Collection Protocol

F

Fore Biotherapeutics

Status

Completed

Conditions

Patients Eligible for Tumor Biopsy
Patients That Have Been Diagnosed With Colorectal Cancer

Study type

Observational

Funder types

Industry

Identifiers

NCT01791322
PM 01.1

Details and patient eligibility

About

NovellusDx is developing a diagnostic platform for the personalized cancer therapy based on patient derived tumor tissue. The assay is able to sense activating mutations by monitoring their effect on a chip-based device.

Enrollment

15 patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients that have been diagnosed positive for colon cancer.
  • available treatment follow up during cancer treatment

Exclusion criteria

  • None

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems